/PRVCF
PRVCF Stock - PreveCeutical Medical Inc.
Healthcare|BiotechnologyOTC
$0.02-24.73%
$0.01 (-24.73%) • Dec 19
67
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.48
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.100
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $0.02
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for PRVCF
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$0.02 – $0.02
TARGET (TP)$0.02
STOP LOSS$0.02
RISK/REWARD1:-1.0
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta0.16
52W High$0.04
52W Low$0.00
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | N/A | N/A | N/A | N/A | N/A |
| Gross Profit | N/A | $-9,856 | $-9,891 | $-5,091 | $-75,165 |
| Gross Margin | N/A | N/A | N/A | N/A | N/A |
| Operating Income | $-812,466 | $-963,000 | $-1,058,820 | $-898,000 | $-2,140,000 |
| Net Income | $-1,174,677 | $-1,274,000 | $-1,481,000 | $-1,727,000 | $-3,801,000 |
| Net Margin | N/A | N/A | N/A | N/A | N/A |
| EPS | $-0.00 | $-0.00 | $-0.00 | $-0.00 | $-0.01 |
Company Overview
PreveCeutical Medical Inc., a health sciences company, engages in the development of options for preventive and curative therapies utilizing organic and nature identical products. Its pipeline products include Cannabinoid Sol-Gel Delivery, a cannabinoid-based nose-to-brain delivery system that provides relief from various indications, including pain, inflammation, seizures, and neurological disorders; BSV Peptide Program for targeting cancer progression; Non-Addictive Analgesic for pain management; and Dual Gene Therapy for type 2 diabetes and obesity. The company also develops a range of medicinal cannabis-based products. PreveCeutical Medical Inc. is headquartered in Vancouver, Canada.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
PRVCFBeat Rate
0%
Last 0 quarters
Avg Surprise
+0%
EPS vs Estimate
Beats / Misses
0/0
Last 12 quarters
Latest EPS
$-0.00
Q3 2025
EPS Surprise History
Q4 23
No data
Q1 24
No data
Q2 24
No data
Q3 24
No data
Q4 24
No data
Q2 25
No data
Q2 25
No data
Q3 25
No data
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q3 2025 | Aug 29, 2025 | — | $-0.00 | — | — |
Q2 2025 | May 30, 2025 | — | $-0.00 | — | — |
Q2 2025 | Apr 30, 2025 | — | $-0.00 | — | — |
Q4 2024 | Nov 27, 2024 | — | $-0.00 | — | — |
Q3 2024 | Jul 5, 2024 | — | $-0.00 | — | — |
Q2 2024 | Jun 28, 2024 | — | $-0.00 | — | — |
Q1 2024 | Mar 30, 2024 | — | $-0.00 | — | — |
Q4 2023 | Nov 21, 2023 | — | $-0.00 | — | — |
Q3 2023 | Sep 30, 2023 | — | $-0.00 | — | — |
Q2 2023 | May 30, 2023 | — | $-0.00 | — | — |
Q2 2023 | May 1, 2023 | — | $0.00 | — | — |
Q4 2022 | Nov 25, 2022 | — | $-0.00 | — | — |
Q3 2022 | Aug 24, 2022 | — | $-0.00 | — | — |
Q2 2022 | May 30, 2022 | — | $-0.00 | — | — |
Q2 2022 | May 2, 2022 | — | $-0.00 | — | — |
Q4 2021 | Nov 29, 2021 | — | $-0.00 | — | — |
Q3 2021 | Aug 30, 2021 | — | $-0.00 | — | — |
Q2 2021 | May 31, 2021 | — | $-0.00 | — | — |
Q2 2021 | Apr 13, 2021 | — | $-0.00 | — | — |
Q4 2020 | Nov 27, 2020 | — | $0.00 | — | — |
Latest News
Loading news...
Frequently Asked Questions about PRVCF
What is PRVCF's current stock price?
PreveCeutical Medical Inc. (PRVCF) is currently trading at $0.02 per share. The stock has moved -24.73% today.
What is the analyst price target for PRVCF?
No analyst price targets are currently available for this stock.
What sector is PreveCeutical Medical Inc. in?
PreveCeutical Medical Inc. operates in the Healthcare sector, specifically within the Biotechnology industry. The company is traded on the OTC exchange.
What is PRVCF's market cap?
PreveCeutical Medical Inc. has a market capitalization of $0.01 billion, making it a small-cap company.
Does PRVCF pay dividends?
No, PreveCeutical Medical Inc. does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorCLCS
Cell Source, Inc.
$0.50
Mkt Cap: $0.0B
GLABF
Gemina Laboratories Ltd.
$0.09
Mkt Cap: $0.0B
HMTXF
Hemostemix Inc.
$0.06
Mkt Cap: $0.0B
IMUC
EOM Pharmaceuticals Holdings, Inc.
$0.15
Mkt Cap: $0.0B
PPCB
Propanc Biopharma, Inc.
$0.71
Mkt Cap: $0.0B
QPTFF
Quest PharmaTech Inc.
$0.01
Mkt Cap: $0.0B
SRBCF
Sirona Biochem Corp.
$0.01
Mkt Cap: $0.0B
SYGGF
Synairgen plc
$0.00
Mkt Cap: $0.0B
TELIF
Telescope Innovations Corp.
$0.25
Mkt Cap: $0.0B
ZHCLF
Zenith Capital Corp.
$0.00
Mkt Cap: $0.0B
Explore stocks similar to PRVCF for comparison